Repare Therapeutics Inc.
RPTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $75,619 | $59,661 | $41,991 | $55,559 |
| - Cash | $72,825 | $67,656 | $84,455 | $84,717 |
| + Debt | $342 | $649 | $1,372 | $1,933 |
| Enterprise Value | $3,136 | -$7,346 | -$41,092 | -$27,225 |
| Revenue | $11,620 | $250 | $0 | $0 |
| % Growth | 4,548% | – | – | – |
| Gross Profit | $11,620 | $250 | -$1,186 | -$454 |
| % Margin | 100% | 100% | – | – |
| EBITDA | $3,475 | -$19,026 | -$28,352 | -$28,077 |
| % Margin | 29.9% | -7,610.4% | – | – |
| Net Income | $3,258 | -$16,744 | -$30,043 | -$28,671 |
| % Margin | 28% | -6,697.6% | – | – |
| EPS Diluted | 0.08 | -0.39 | -0.71 | -0.67 |
| % Growth | 120.5% | 45.1% | -6% | – |
| Operating Cash Flow | $2,651 | -$16,342 | -$29,133 | -$27,324 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $2,651 | -$16,342 | -$29,133 | -$27,324 |